2929 — Pharma Foods International Co Share Price
- ¥26bn
- ¥28bn
- ¥62bn
- 90
- 71
- 78
- 94
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 2.19 | ||
Price to Tang. Book | 2.22 | ||
Price to Free Cashflow | 15.86 | ||
Price to Sales | 0.44 | ||
EV to EBITDA | 5.62 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 29.5% | ||
Return on Equity | 25.09% | ||
Operating Margin | 6.59% |
Financial Summary
Year End 31st Jul | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | ¥m | 15,353.38 | 46,752 | 60,185 | 68,572 | 62,147 | n/a | n/a | 42.62% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +32.35 | +471.24 | n/a | n/a | +9.56 | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Pharma Foods International Co., Ltd. is a Japan-based company mainly engaged in mail order business and functional materials business. The Company operates through three business segments. The Mail Order segment is engaged in the sale of supplement Tamagosamin, cosmetics Pearl Skin Lanchel and Derma QII Mild Peeling Gel, through advertising media such as televisions and radios. The Functional Materials segment is engaged in the development and sale of functional materials such as GABA, Bonepep, Folic Acid eggs and Chicken Egg Antibody. The Company is also engaged in the planning and sale of original equipment manufacturer (OEM) products such as supplements and beverages. The Biomedical segment is engaged in the antibody contract manufacture business for drug discovery and diagnostics, and life science information (LSI) business for analysis and efficacy evaluation test of materials and products.
Directors
- Mujo Kim PRE (65)
- Kazuyuki Masuda SMD (45)
- Noriko Horie MDR (52)
- Yasunori Inoue MDR (44)
- Masayoshi Aosasa DRC (50)
- Shinya Samura IND (66)
- Taro Ueda IND (61)
- Tetsuro Yamane IND (72)
- Last Annual
- July 31st, 2024
- Last Interim
- January 31st, 2025
- Incorporated
- September 12th, 1997
- Public Since
- June 12th, 2006
- No. of Shareholders
- 17,211
- No. of Employees
- 642
- Sector
- Biotechnology & Medical Research
- Industry
- Healthcare
- Exchange
Tokyo Stock Exchange
- Shares in Issue
- 29,059,031

- Address
- 1-49, Goryo-Ohara, Nishikyo-ku, KYOTO-SHI, 615-8245
- Web
- https://www.pharmafoods.co.jp/
- Phone
- +81 753948600
- Auditors
- Kainan Audit Corporation
Upcoming Events for 2929
Dividend For 2929.T - 12.5000 JPY
Similar to 2929
3-D Matrix
Tokyo Stock Exchange
AnGes
Tokyo Stock Exchange
BrightPath Biotherapeutics Co
Tokyo Stock Exchange
Carna Biosciences
Tokyo Stock Exchange
Chiome Bioscience
Tokyo Stock Exchange
FAQ
As of Today at 22:37 UTC, shares in Pharma Foods International Co are trading at ¥908. This share price information is delayed by 15 minutes.
Shares in Pharma Foods International Co last closed at ¥908 and the price had moved by +9.53% over the past 365 days. In terms of relative price strength the Pharma Foods International Co share price has outperformed the Nikkei 225 Index by +15.43% over the past year.
The overall consensus recommendation for Pharma Foods International Co is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Pharma Foods International Co dividend yield is 3.03% based on the trailing twelve month period.
Last year, Pharma Foods International Co paid a total dividend of ¥28, and it currently has a trailing dividend yield of 3.03%.Looking ahead, shares in Pharma Foods International Co are due to go ex-dividend on 2025-07-30 and the next dividend pay date is 2025-10-01.
Pharma Foods International Co are due to go ex-dividend on 2025-07-30 and the next dividend pay date is 2025-10-01. The historic dividend yield on Pharma Foods International Co shares is currently 3.03%.
To buy shares in Pharma Foods International Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of ¥908, shares in Pharma Foods International Co had a market capitalisation of ¥26bn.
Here are the trading details for Pharma Foods International Co:
- Country of listing: Japan
- Exchange: TYO
- Ticker Symbol: 2929
Based on an overall assessment of its quality, value and momentum Pharma Foods International Co is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Pharma Foods International Co is ¥3,017. That is 232.23% above the last closing price of ¥908.
Analysts covering Pharma Foods International Co currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pharma Foods International Co. Over the past six months, its share price has outperformed the Nikkei 225 Index by +16.18%.
As of the last closing price of ¥908, shares in Pharma Foods International Co were trading -3.56% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Pharma Foods International Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at ¥908.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Pharma Foods International Co's management team is headed by:
- Mujo Kim - PRE
- Kazuyuki Masuda - SMD
- Noriko Horie - MDR
- Yasunori Inoue - MDR
- Masayoshi Aosasa - DRC
- Shinya Samura - IND
- Taro Ueda - IND
- Tetsuro Yamane - IND